Abstract
Maternal mortality is increasing in the United States; many maternal deaths are linked to substandard care and withholding diagnostic tests or therapeutic options for fear of harm. Respiratory conditions are common in this population; however, caring for pregnant women with respiratory disease is complicated by physiologic changes. Safety of diagnostic tests as well as therapeutic interventions, changes in pharmacodynamics, and potential teratogenicity complicate the care of this population further. Appropriate care of pregnant women with respiratory conditions requires a good understanding of these nuances in the management, to provide appropriate care and improve the health and well-being of pregnant women.